Method for determining optimum intraocular locations for drug delivery systems
AssigneeAllergan, Inc.
InventorsMichael R. Robinson, Joan-En Chang-Lin, Devin F. Welty, Scott M. Whitcup, Patrick M. Hughes
Life of this patent
Estimating the term…
Abstract
A method for determining the optimum location for placement of an intraocular implant containing used to treat an ocular condition, particularly implants comprised of a biodegradable polymer and a therapeutic agent for the treatment of retinal tissue.
Claims5
A method for treating macular edema with a biodegradable intraocular implant, the implant comprising a therapeutic agent and a biodegradable polymer associated with the therapeutic agent, wherein the implant is a cylindrical pellet with dimensions of about 2 mm×0.75 mm diameter, the method comprising the step of:
- placing the implant in the vitreous at a position x that is 1.3 cm from the aqueous humor and 0.8 cm from the macula thereby treating the macular edema.
Dependencies are inferred from the claim text.